410 related articles for article (PubMed ID: 23761921)
1. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Willenberg T; Smith PC; Shepherd A; Davies AH
Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
[TBL] [Abstract][Full Text] [Related]
2. Sclerotherapy and foam sclerotherapy for varicose veins.
Coleridge Smith P
Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
[TBL] [Abstract][Full Text] [Related]
3. European guidelines for sclerotherapy in chronic venous disorders.
Rabe E; Breu FX; Cavezzi A; Coleridge Smith P; Frullini A; Gillet JL; Guex JJ; Hamel-Desnos C; Kern P; Partsch B; Ramelet AA; Tessari L; Pannier F;
Phlebology; 2014 Jul; 29(6):338-54. PubMed ID: 23559590
[TBL] [Abstract][Full Text] [Related]
4. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
Bossart S; Daneluzzi C; Cazzaniga S; Ramelet AA; Uthoff H; Seyed Jafari SM; Baumgartner M; Hunger RE; Heidemeyer K; Willenberg T
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):274-283. PubMed ID: 36196455
[TBL] [Abstract][Full Text] [Related]
5. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
Frullini A; Cavezzi A
Dermatol Surg; 2002 Jan; 28(1):11-5. PubMed ID: 11991262
[TBL] [Abstract][Full Text] [Related]
6. Sclerosants: a comparative review.
Duffy DM
Dermatol Surg; 2010 Jun; 36 Suppl 2():1010-25. PubMed ID: 20590708
[TBL] [Abstract][Full Text] [Related]
7. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
Conrad P; Malouf GM; Stacey MC
Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
[TBL] [Abstract][Full Text] [Related]
8. Complications and side-effects of foam sclerotherapy.
Guex JJ
Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
[TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
10. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
Connor DE; Joseph JE; Exner T; Ma DD; Parsi K
Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013
[TBL] [Abstract][Full Text] [Related]
11. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
[TBL] [Abstract][Full Text] [Related]
12. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study.
Peterson JD; Goldman MP
Phlebology; 2012 Mar; 27(2):73-6. PubMed ID: 21926097
[TBL] [Abstract][Full Text] [Related]
13. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
Star P; Connor DE; Parsi K
Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
[TBL] [Abstract][Full Text] [Related]
14. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins.
Fisher DA
Dermatol Surg; 2000 Nov; 26(11):1082. PubMed ID: 11096404
[No Abstract] [Full Text] [Related]
15. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
Tessari L; Cavezzi A; Frullini A
Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
17. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations.
Whiteley MS; Dos Santos SJ; Fernandez-Hart TJ; Lee CT; Li JM
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):421-8. PubMed ID: 26790396
[TBL] [Abstract][Full Text] [Related]
18. Neurological complications of sclerotherapy for varicose veins.
Sarvananthan T; Shepherd AC; Willenberg T; Davies AH
J Vasc Surg; 2012 Jan; 55(1):243-51. PubMed ID: 21840152
[TBL] [Abstract][Full Text] [Related]
19. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
Rabe E; Pannier F
Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
[TBL] [Abstract][Full Text] [Related]
20. The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.
O'Hare JL; Earnshaw JJ
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):232-5. PubMed ID: 17507258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
